TP53 and breast carcinoma: Incidentally, anti-TP53 has been shown to have detection marker potential in HGSOC [81] and preliminary results by our group in a set of 728 sera (123 ovarian cancer cases, 369 healthy controls, 144 benign ovarian disease, 92 surgical controls) showed performance similar to that reported here in breast cancer (unpublished).